GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (FRA:7V3) » Definitions » Interest Expense (Positive)

Cantargia AB (FRA:7V3) Interest Expense (Positive)


View and export this data going back to 2018. Start your Free Trial

What is Cantargia AB Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Cantargia AB Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.